Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Quality in Sport

Beta-Adrenoceptor Antagonists and the Physiological Response to Exercise: Clinical Implications for Training and Rehabilitation
  • Home
  • /
  • Beta-Adrenoceptor Antagonists and the Physiological Response to Exercise: Clinical Implications for Training and Rehabilitation
  1. Home /
  2. Archives /
  3. Vol. 53 (2026) /
  4. Health Sciences

Beta-Adrenoceptor Antagonists and the Physiological Response to Exercise: Clinical Implications for Training and Rehabilitation

Authors

  • Agnieszka Olejnik Independent Public Healthcare Institution MSWiA in Lodz, Poland https://orcid.org/0009-0002-4180-5270
  • Mateusz Zdaniewicz The Brothers Hospitallers of Saint John Grande Hospital, Cracow, Poland https://orcid.org/0009-0003-2157-7941
  • Jakub Adamiak Medical University of Lodz, al. Tadeusza Kosciuszki 4, 90-419 Lodz, Poland https://orcid.org/0009-0009-2344-6164
  • Michał Maciejowski Central Teaching Hospital of Medical Uniwersity of Lodz FYI, Poland https://orcid.org/0009-0004-5847-9592
  • Bartłomiej Czyżak Independent Public Healthcare Institution MSWiA in Lodz, Poland https://orcid.org/0009-0006-3375-9955
  • Adrian Baran Faculty of Medicine, Jagiellonian University Medical College, ul. sw. Anny 12, 31-008 Cracow, Poland https://orcid.org/0009-0000-5658-076X
  • Justyna Jankowska Independent Public Healthcare Institution MSWiA in Lodz, Poland https://orcid.org/0009-0006-0225-2668
  • Konrad Gronek Independent Public Healthcare Institution MSWiA in Lodz, Poland https://orcid.org/0009-0008-7812-5432
  • Beata Huszcza Municipal Medical Centre of Karol Jonscher in Lodz, Poland https://orcid.org/0009-0002-2168-5275
  • Edward Zheng Independent Public Healthcare Institution MSWiA in Lodz, Poland https://orcid.org/0009-0009-0496-293X

DOI:

https://doi.org/10.12775/QS.2026.53.69721

Keywords

beta-blockers, beta-adrenoceptor antagonists, exercise capacity, ventilatory threshold, cardiopulmonary exercise testing

Abstract

Aim: This narrative review aimed to analyze the impact of beta-adrenoceptor antagonists on the physiological response to exercise and to identify clinical implications for exercise training prescription and exercise-based rehabilitation in patients receiving long-term pharmacotherapy. 

Material and Methods: A structured literature search was conducted in PubMed, Embase, and the Cochrane Library for studies published between January 2018 and February 2026. Randomized controlled trials, crossover studies, observational research, and relevant systematic reviews evaluating the effects of cardioselective and non-selective beta-adrenoceptor antagonists on peak oxygen uptake (VO₂peak), heart rate response, and ventilatory thresholds in healthy and clinical populations were included. Due to heterogeneity in study design, populations, and pharmacological regimens, findings were synthesized narratively without quantitative meta-analysis. 

Results: Beta-adrenoceptor antagonists consistently attenuate the chronotropic response to exercise, typically reducing maximal heart rate by approximately 18–19%. Despite this effect, VO₂peak and maximal power output are often preserved through compensatory mechanisms such as increased stroke volume and enhanced arteriovenous oxygen extraction. Under beta-blockade, the relationship between heart rate and external workload becomes blunted, limiting the reliability of heart rate–based methods (e.g., %HRmax, HRR) for exercise intensity prescription. 

Conclusions: Exercise-based rehabilitation in patients treated with beta-adrenoceptor antagonists requires an individualized, physiology-guided approach. Cardiopulmonary exercise testing with determination of ventilatory thresholds (VT1 and VT2) should be preferred for exercise prescription. In settings without access to CPET, subjective measures such as the Borg Rating of Perceived Exertion scale and the talk test should be incorporated to ensure safety and training effectiveness. 

References

1. Andersen JT, Ergen E, Hazir T, et al. Effects of beta-blockers on archery performance, body sway and aiming behaviour: a randomised, double-blind, placebo-controlled, cross-over trial. BMJ Open Sport Exerc Med. 2021;7(2):e001071. doi:10.1136/bmjsem-2021-001071

2. Mendes RG, Castro R, Araujo CJ, Maia FL. Beta-blockers and exercise tolerance. Rev Bras Anestesiol. 2004;54(2):232–241.

3. Vanhees L, Fagard R, Thijs L, Amery A. Influence of beta-blockade on exercise capacity. Prog Cardiovasc Dis. 2004;46(5):365–372. doi:10.1016/j.pcad.2003.11.003

4. Priel E, Friedmann O, Smolev M, Sharabi Y, Weinstock-Guttman B. Acute beta1-blockade does not reduce maximal oxygen uptake in healthy adults. Front Physiol. 2021;12:656345. doi:10.3389/fphys.2021.656345

5. Montero D, Flammer AJ. Effect of beta-blockers on V̇O₂peak in heart failure: systematic review and meta-analysis. Sports Med. 2018;48(8):1605–1617. doi:10.1007/s40279-018-0969-2

6. Birnbaumer P, Auersperger I, Hotter B, et al. Pattern of the heart rate performance curve in beta-blocked subjects and healthy controls. Sports. 2018;6(3):61. doi:10.3390/sports6030061

7. Pelliccia A, Sharma S, Gati S, et al. Exercise intensity assessment and prescription in cardiovascular disease: a clinical update. Eur J Prev Cardiol. 2021;28(12):1303-1318. doi:10.1093/eurjpc/zwab007

8. Wonisch M, Hofmann P, Fruhwald F, et al. Influence of beta-blocker use on percentage of target heart rate exercise prescription. Eur J Cardiovasc Prev Rehabil. 2003;10(4):296–301. doi:10.1097/01.hjr.0000085246.96747.11

9. Mitchell BL, Davison K, Parfitt G, et al. Physiological and perceived exertion responses during exercise: effect of β-blockade. Med Sci Sports Exerc. 2019;51(4):782–791. doi:10.1249/MSS.0000000000001845

10. Mezzani A, Hamm LF, Jones AYM, et al. Cardiopulmonary exercise testing in cardiac rehabilitation: a scientific statement from the American Heart Association. Circulation. 2022;145(17):e1019–e1037. doi:10.1161/CIR.0000000000001075

11. Xie J, Qi F, Zhang H, et al. Beta-blocker effects on exercise capacity and ventilatory threshold. PLoS One. 2022;17(12):e0279171. doi:10.1371/journal.pone.0279171

12. Bangalore S, Messerli FH, Wun CC, et al. β-blocker use and cardiovascular outcomes in contemporary practice: a meta-analysis. Am J Med. 2007;120(2):149-154. doi:10.1016/j.amjmed.2006.08.014

13. Williams B, Mancia G, Spiering W, et al. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023;41(12):1874–2071. doi:10.1097/HJH.0000000000003480

14. Whelton PK, Carey RM, Aronow WS, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018. doi:10.1093/eurheartj/ehae178

15. Dahlöf B. β-blockade for patients with hypertension, ischemic heart disease or heart failure – where are we now? Vasc Health Risk Manag. 2021;17:337–348. doi:10.2147/VHRM.S285907

16. Schmied C, Ostermann M, Hofmann P, et al. Effects of beta-blockade on exercise physiology. Sci Rep. 2020;10(1):79837. doi:10.1038/s41598-020-79837-3

17. Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Beta-blockers in hypertension and cardiovascular disease: a critical reappraisal. Curr Med Res Opin. 2024;40(2):151–164. doi:10.1080/03007995.2024.2318058

18. Bavishi C, Bangalore S, Shamsuzzaman M, et al. Beta-blockers and exercise response: clinical implications. Curr Med Res Opin. 2024;40(1):87–96. doi:10.1080/03007995.2024.2317433

19. Patel HC, Hayward C, Ozkor M, et al. Exercise prescription under beta-blockade. Sports Med. 2013;43(11):1121–1134. doi:10.1007/s40279-013-0095-7

20. Al-Khatib SM, Antman EM, Lamas GA, et al. Adrenergic receptor pharmacology in cardiovascular disease. Curr Cardiol Rev. 2021;17(3):180–190. doi:10.2174/1573403X176662101191009

21. Cojocariu SA, Maștaleru A, Sascău RA, et al. Neuropsychiatric consequences of lipophilic beta-blockers. Medicina (Kaunas). 2021;57(2):155. doi:10.3390/medicina57020155

22. Michel MC, Michel-Reher MB, Hein P. A systematic review of inverse agonism at adrenoceptor subtypes. Cells. 2020;9(9):1923. doi:10.3390/cells9091923.

23. Hundemer GL, Canney M. β-blockers in hemodialysis: simple questions, complicated answers. Clin Kidney J. 2021;14(3):731–734. doi:10.1093/ckj/sfaa249.

24. AlHabeeb W, Mrabeti S, Abdelsalam AAI. Therapeutic properties of highly selective β-blockers with or without additional vasodilator properties: focus on bisoprolol and nebivolol in patients with cardiovascular disease. Cardiovasc Drugs Ther. 2022;36:959–971. doi:10.1007/s10557-021-07205-y.

25. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368.

26. Assimon MM, Flythe JE. A comparative study of carvedilol versus metoprolol initiation and mortality risk among patients receiving maintenance hemodialysis. Am J Kidney Dis. 2018;72(3):337–348. doi:10.1053/j.ajkd.2018.02.358

27. Hundemer GL, Curhan GC. Beta-blocker use and outcomes in patients with chronic kidney disease. Clin Kidney J. 2021;14(3):983–991. doi:10.1093/ckj/sfaa289

28. Frishman WH. Beta-adrenergic blockade in cardiovascular disease. J Clin Hypertens. 2016;18(11):1032–1041. doi:10.1111/jch.12864

29. Carerj S, Zito C, Di Bella G, et al. Left ventricular deformation analysis by speckle tracking echocardiography in cardiovascular disease. Int J Cardiovasc Imaging. 2019;35(7):1231–1240. doi:10.1007/s10554-019-01560-6

30. Bryniczka I, Jezierski M, Nowicka E, Patrzykąt KM, Gorzoch-Burduk Z, Puzio J, Marcinkowska P, Krzyżaniak M, Popielarska K, Wróblewska K. Old drugs, new roles: non-cardiac uses of beta-blockers – an updated systematic review. Quality in Sport. 2025;48:66932. doi:10.12775/QS.2025.48.66932.

Quality in Sport

Downloads

  • PDF

Published

2026-03-18

How to Cite

1.
OLEJNIK, Agnieszka, ZDANIEWICZ, Mateusz, ADAMIAK, Jakub, MACIEJOWSKI, Michał, CZYŻAK, Bartłomiej, BARAN, Adrian, JANKOWSKA, Justyna, GRONEK, Konrad, HUSZCZA, Beata and ZHENG, Edward. Beta-Adrenoceptor Antagonists and the Physiological Response to Exercise: Clinical Implications for Training and Rehabilitation. Quality in Sport. Online. 18 March 2026. Vol. 53, p. 69721. [Accessed 21 April 2026]. DOI 10.12775/QS.2026.53.69721.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 53 (2026)

Section

Health Sciences

License

Copyright (c) 2026 Agnieszka Olejnik, Mateusz Zdaniewicz, Jakub Adamiak, Michał Maciejowski, Bartłomiej Czyżak, Adrian Baran, Justyna Jankowska, Konrad Gronek, Beata Huszcza, Edward Zheng

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 246
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

beta-blockers, beta-adrenoceptor antagonists, exercise capacity, ventilatory threshold, cardiopulmonary exercise testing
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop